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ALERT 
Many patients with generalized anxiety disorder (GAD) experience 
helplessness and are at risk for self-harm.14 
 
Patients with GAD typically seek help from primary care practitioners for 
physical symptoms of the disorder, and the anxiety disorder goes 
unrecognized.3 
 
OVERVIEW 
GAD is one of the most common anxiety disorders. The chief symptom is the 
experience of persistent and excessive worry about general events that are out of 
proportion to the reality of the patient’s situation. The worrying thoughts can lead to 
significant dysfunction. Presenting symptoms may also be physical, such as 
headaches or abdominal distress.12 According to the Diagnostic and Statistical 
Manual of Mental Disorders, 5th edition (DSM-5), the defining diagnostic criteria 
(300.02 [F41.1]) include:2 
• Excessive anxiety and worry (apprehensive expectation) that occurs more days 
than not, for at least 6 months, about a number of events or activities (e.g., 
work, school performance). 
• The patient finds it difficult to control the worry. 
• The anxiety and worry are associated with three (or more) of these six symptoms 
(with at least some symptoms being present for more days than not for the past 
6 months): 
o Restlessness or feeling keyed up or on edge 
o Being easily fatigued 
o Difficulty concentrating or the mind going blank 
o Irritability 
o Muscle tension 
o Sleep disturbance (difficulty falling or staying asleep or restless, 
unsatisfying sleep) 
• The anxiety, worry, or physical symptoms cause clinically significant distress or 
impairment in social, occupational, or other important areas of functioning. 
 
In addition, the signs and symptoms of GAD are not due to another condition or in 
response to medications or substance use.2 Conditions that may have some 
symptoms similar to GAD include hyperthyroidism and substance use or withdrawal.3 
 
GAD is a chronic condition, in most cases affecting women, that can cause significant 
disability and higher use of emergency services.4 GAD affects physical, cognitive, 
emotional, and behavioral aspects of a patient’s life. Patients can experience physical 
symptoms such as headaches, abdominal distress, sleep disturbances, and muscle 
tension. In most cases, these are the primary presenting symptoms described by the 
patient.12 Cognitive aspects include difficulty concentrating or an inability to focus. 
Emotional and behavioral aspects may involve restlessness and avoidance.3 
 
Patients with GAD have a heightened likelihood of experiencing co-occurring 
psychiatric and medical conditions, including depression, chronic pain conditions, 
irritable bowel disease, and asthma. A history of abuse is a risk factor for the 
development of GAD.14 
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GAD, panic disorder, and phobias have a negative impact on personality functioning, 
which can become severe for patients with comorbid personality disorders.5 
 
EDUCATION 
• Establish a rapport with the patient, family, and designated support person that 
encourages questions. Answer them as they arise. 
• Consider the patient’s, family’s, and designated support person’s values and 
goals in the decision-making process. 
• Assist the patient, family, and designated support person to recognize signs and 
symptoms of acute exacerbation of the illness. 
• Explain the manifestations of the illness and expected progression of symptoms if 
the patient experiences a relapse. Describe what the family and designated 
support person are likely to see, hear, and experience (e.g., persistent worry, 
irritability, jitteriness, somatic symptoms such as headache, nausea, sleep 
disturbances, difficulty concentrating or making decisions). Advise the patient, 
family, and designated support person of steps to take if relapse occurs. 
• Explain to the patient, family, and designated support person that the main goal 
is to provide a safe, secure place to receive treatment. 
• Explain how the behavioral health unit may be different than other settings. 
Interaction is promoted between patients and staff, and group meetings are 
encouraged. To ensure the patients’ safety, they are checked on frequently 
throughout the day. 
• Educate the family and designated support person regarding the nature of 
psychiatric illness and expected signs and symptoms (e.g., persistent worry, 
irritability, jitteriness, somatic symptoms such as headache, nausea, sleep 
disturbances, difficulty concentrating or making decisions).  
• Assist the patient, family, and designated support person to engage and 
participate as drivers of the plan of care. 
• Explain the importance of following the medication regimen as ordered. The 
patient should not alter dosage or stop taking the medication even if symptoms 
have subsided and he or she is feeling better. 
• Educate the patient, family and designated support person about the chronic 
nature of the disorder. 
• Educate the patient, family, and designated support person about the risks of 
self-harm and suicide that are associated with GAD. 
• Educate the patient, family, and designated support person about emergency 
resources. 
 
ASSESSMENT 
1. Perform hand hygiene.  
2. Introduce yourself to the patient, family, and designated support person. 
3. Verify the correct patient using two identifiers. 
4. Assess the patient’s mental status and ability to understand information and 
participate in decisions. Include the patient as much as possible in all decisions. 
5. Assess the patient for suicidal or homicidal ideation or thoughts of self-harm. A 
patient with GAD may experience a sense of helplessness and become suicidal or 
engage in self-harm behaviors.14 
6. Evaluate the patient’s, family’s, and designated support person’s understanding 
of the patient’s illness. 
7. Assess and discuss the patient’s goal for treatment.  
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8. Collaborate with the patient, family, and designated support person to develop a 
plan of care. 
9. Identify the patient’s psychiatric advance directives, if available. 
10. Determine the patient’s desire for the family or designated support person to be 
kept informed and involved in treatment. 
11. Determine the family’s or designated support person’s ability to support the 
patient during treatment. 
12. Assess the patient’s symptoms of GAD and its impact on his or her ability to 
function. 
13. Assess the patient for medical conditions that may mimic the symptoms of GAD. 
 
Rationale: Patients with GAD may experience physical signs and 
symptoms, somatic signs and symptoms, or both, such as tachycardia, 
diaphoresis, elevated blood pressure, increased respirations, and pain, 
stomach distress, headaches, or muscle tension; therefore, it is 
important to rule out medical conditions that may also manifest these 
signs and symptoms.14 
 
14. Assess the patient for nonverbal expressions of GAD, such as tense facial 
muscles, fidgeting, restlessness, or guardedness.  
15. Use an organization-approved assessment scale (e.g., Hamilton Anxiety Scale) to 
assess anxiety. 
16. Assess the patient’s use of alcohol, nicotine, or illicit substances. In many cases, 
a patient with GAD will self-medicate with alcohol or other substances to reduce 
symptoms.14 
17. Assess the patient’s need for assistance in performing self-care activities. 
 
STRATEGIES 
1. Perform hand hygiene.  
2. Verify the correct patient using two identifiers.  
3. Assess the patient for suicidal or homicidal ideation or thoughts of self-harm, and 
if present, implement appropriate precautions based on the patient's status. 
 
Rationale: Patients with GAD and chronic pain conditions are at 
heightened risk for suicide.13 
 
4. Explain the strategies to the patient, family, and designated support person and 
ensure that they agree to treatment. Ensure that the patient understands the 
information presented. 
 
Rationale: GAD may interfere with the patient’s ability to understand 
information. It is important to ensure that the patient’s level of anxiety 
allows him or her to process information.3 
 
5. Maintain a calm, collaborative communication approach, avoiding the use of 
coercion. 
6. Create an environment of trust that allows the development of a therapeutic 
relationship. 
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7. Orient the patient to the unit. Include discussion of unit routines, guidelines, 
patients’ rights and expectations, and schedules. Inform the patient that he or 
she will be checked on frequently throughout the stay. 
8. Create an environment that advocates for the patient’s needs using an 
interdisciplinary team. Engage the team in collaborative assessment and 
treatment planning with the patient. 
9. Engage the patient in treatment, including participation in therapeutic groups and 
individual sessions. 
10. Administer psychiatric medications as ordered and monitor the patient’s response 
to the medications.  
11. Monitor the patient’s responses and social interactions in the milieu; reinforce 
appropriate social skills. 
12. Implement appropriate precautions based on the patient’s status. 
13. Respond to crisis in a calm, therapeutic, and nonthreatening manner. Use the 
least restrictive interventions to prevent harm to patients or staff. 
14. Review physical and somatic signs and symptoms in addition to emotional and 
cognitive signs and symptoms the patient may be experiencing.  
 
Rationale: Patients with GAD experience debilitating signs and 
symptoms, which can be physical, cognitive, emotional, and 
behavioral. Patient’s physical symptoms, such as headaches, 
abdominal distress, sleep disturbances, and muscle tension, may be 
the primary presenting symptoms described by him or her.12 
 
15. When discussing the patient’s concerns, avoid focusing on specific issues or items 
that he or she is worried about; focus on the experience of worrying excessively. 
 
Rationale: Patients frequently seek reassurance about the immediate 
focus of their concern. It is important to avoid reinforcing that focus and 
to refocus the patient on the pervasive nature of the anxiety.3 
 
16. Assess the methods the patient uses to cope with symptoms of anxiety.  
 
Rationale: Patients with GAD frequently use maladaptive coping skills, 
such as hypervigilance, checking behaviors, and avoidance, to reduce 
their worry.9  
 
17. Engage the patient in developing the plan of care and provide support and 
encouragement as needed. 
 
Rationale: Patients with GAD frequently become preoccupied with worry 
and have difficulty functioning.3 
 
18. Consider using a standardized assessment scale to determine baseline signs and 
symptoms.  
 
Rationale: Use of a standardized tool, such as the Generalized Anxiety 
Disorder 7 (GAD-7), can benefit in screening the severity of the signs and 
symptoms as well as the patient’s progress in treatment.11,14 
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19. Evaluate the patient for co-occurring psychiatric and medical conditions that may 
negatively impact the patient’s status. 
 
Rationale: Patients with GAD frequently have co-occurring psychiatric and 
medical conditions such as depression, chronic pain, and irritable bowel 
disease. These comorbidities can increase the severity of the signs and 
symptoms the patient experiences.3  
 
20. Collaborate with the patient, family, designated support person, and team in 
planning for patient discharge and follow-up care. 
21. Provide the appropriate education related to medications, crisis management, 
and follow-up care to the patient, family, and designated support person at the 
time of discharge. 
22. Explain to the patient, family, and designated support person that ongoing 
treatment is vital to continuing recovery. Making and keeping follow-up 
appointments is critical. 
23. Perform hand hygiene. 
24. Document the strategies in the patient’s record. 
 
REASSESSMENT 
1. Assess the patient for decreased symptoms of GAD. 
2. Assess the patient’s ability to recognize his or her signs and symptoms of GAD. 
3. Assess the patient’s ability to comprehend and retain instructions and 
information. 
4. Reassess the patient’s pain status and provide appropriate pain management 
(e.g., medication, relaxation, mindfulness skills).  
 
EXPECTED OUTCOMES 
• Health care team members, patient, family, and designated support person 
recognize symptoms of GAD and triggers. 
• Patient verbalizes symptoms of GAD. 
• Patient participates in the assessment process. 
 
UNEXPECTED OUTCOMES 
• Patient is unable to verbalize symptoms of GAD. 
• Patient is unwilling or unable to participate in assessment process. 
• Patient is unable to follow directions and retain educational information. 
 
DOCUMENTATION 
• Patient, family, and support person education 
• Assessment of pain, treatment if necessary, and reassessment  
• Observed signs of GAD 
• Reported symptoms of GAD 
• Standardized tools used to assess GAD  
• Patient’s, family’s, and designated support person’s understanding of GAD 
• Family’s and support person’s involvement in patient’s assessment and care 
• Consultation requests and referrals 
• Patient’s behaviors and response to interventions  
• Patient’s progress toward goals  
  
Anxiety: Generalized Anxiety Disorder 
Assessment (Behavioral Health) - CE 
Copyright © 2020, Elsevier, Inc. All rights reserved.           6 of 7 
ADOLESCENT CONSIDERATIONS 
• GAD is a common disorder among adolescents. Risk factors for the development 
of GAD in adolescents include a history of trauma, exposure to violence, and 
parental anxiety disorder. The assessment process for adolescents should include 
the family.7 
• The Screen for Child Anxiety Related Emotional Disorders Revised (SCARED-R) 
and the Screen for Child Anxiety Related Emotional Disorders (SCARED) are both 
tools that can be used to screen for GAD in children and adolescents.8 
 
OLDER ADULT CONSIDERATIONS 
• GAD is common in older adults and has significant consequences regarding 
quality of life, health, and functioning. 
• Older adults with GAD experience more sleep disturbances and depression than 
younger patients with GAD.1 
• The Rating Anxiety in Dementia (RAID) scale has demonstrated validity and 
sensitivity in identifying anxiety in patients with dementia.6 
 
SPECIAL CONSIDERATIONS 
• Careful evaluation is required to prevent misidentifying signs and symptoms of 
the disorder as normal worry and changes experienced during pregnancy.10 
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